🇰🇷 Aldomet in South Korea

Aldomet (METHYLDOPATE) regulatory status in South Korea.

Marketing authorisation

MFDS

  • Status: likely_approved

Aldomet in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Cardiovascular approved in South Korea

Frequently asked questions

Is Aldomet approved in South Korea?

Yes. MFDS has authorised it.

Who is the marketing authorisation holder for Aldomet in South Korea?

Merck & Co. is the originator. The local marketing authorisation holder may differ — check the official source linked above.